Physician and Pharmacist Managed Warfarin Treatment in Open Heart Surgery Patients

Context

Surgeons have historically adjusted the dosage of warfarin in our institution. To more efficiently utilize the skills of both surgeons and pharmacists, the dosage of warfarin was delegated to pharmacists.

Objectives

To compare the effectiveness of pharmacists to physicians in obtaining therapeutic anticoagulation upon initiation of warfarin therapy. Secondary objectives included: the percentage of days when the INR was >4 or <2, the time to stabilize the INR within the therapeutic range, and the percentage of patients experiencing at least one major bleed.

Setting

Cardiac Surgery wards of a tertiary teaching hospital.

Design

This study was a retrospective chart review of patients who received warfarin following cardiac valve surgery. Pharmacists utilized a warfarin nomogram to manage patients; physicians dosed independently.

Main Outcome Measures

Percentage of therapy days within the target INR range; percentage of therapy days with INR less than 2 or greater than 4.

Results

This study consisted of 227 patients (pharmacist group: 97; physician group: 130). There was no difference found between the two groups in the percentage of days in the therapeutic range (p-value=0.27), the percentage of days with INR <2 (p-value=0.06), the percentage of patients discharged before their INR stabilized (p-value=0.91) and the percentage of patients with a major bleed (p-value=0.72). The pharmacist group had 6% fewer days of INR >4 than the physician group and this was statistically significant (p-value of <0.001).

Conclusions

Pharmacists are equally safe and effective as physicians when managing warfarin therapy in patients who have undergone cardiac valve replacement.

Latest Posts